Enclomiphene vs Testosterone Cream: Which One Fits You?

Enclomiphene vs testosterone cream is not a choice between two flavors of the same treatment. Enclomiphene stimulates your own production; cream supplies testosterone. The right discussion depends on repeat morning tests, the cause of low testosterone, fertility plans, and transfer risk—not LH alone. Head-to-head trials used gel, not cream.

Best fit to discuss: A fertility-aware clinician can assess whether stimulating your own production makes sense; someone needing replacement who wants to avoid injections can discuss topical testosterone. Not ready to choose either: One low result, an unexplained cause, or fertility plans that have not been addressed. Diagnosis and fertility guidance · Comparative trial

By TRT Provider Guide · Last verified: September 2026 · Sources checked September 21, 2026.

Editorial research. This page has not been reviewed by a clinician. Educational information, not medical advice. This comparison concerns U.S. adult men being evaluated for testosterone deficiency—not performance enhancement or gender-affirming care.

Testosterone is a Schedule III controlled substance in the United States and requires a valid prescription from a licensed clinician. DEA schedule · Prescribing information

Enclomiphene vs testosterone cream: what changes?

The largest differences are hormone signaling, fertility considerations and product approval—not a proven head-to-head advantage for a compounded cream. This table separates research findings from current product offers and cost scenarios.

Medical sources: Endocrine Society, randomized trial, pooled research, FDA testosterone information, FDA compounding policy, DEA schedule, and testosterone labeling. Cost source: Hone Premium; the full assumptions appear below. These are budget scenarios, not quotes for an individual prescription.

---

Who is each option best for—and who should look elsewhere?

Enclomiphene is a discussion about stimulating testosterone production; cream is a discussion about replacement. Neither can be selected safely from an LH result alone, and fertility or unresolved health concerns can change the right next step. Endocrine Society · Trial evidence

Enclomiphene is probably worth discussing if:

• A clinician thinks you may have secondary hypogonadism and has evaluated why your hormone signals are low or inappropriately normal
• You want children in the next few years — or you honestly aren't sure yet
• You'd rather keep your own production running than replace it
• You'd take a daily pill over a daily cream

Enclomiphene is not a shortcut around further evaluation if:

• Your clinician suspects primary testicular failure; increasing the signal may not produce an adequate response
• You have a pituitary or testicular condition that hasn't been worked up
• You're currently on testosterone; treatment can change LH and FSH, so those results need clinical context—not a self-directed stop or switch

Testosterone cream is probably worth discussing if:

• Low testosterone is confirmed on separate early-morning tests and you have matching symptoms or signs
• Fertility plans have been discussed before treatment
• You want a needle-free daily treatment format managed by your clinician
• You can follow your exact product's transfer precautions around partners, children and other close contacts

A cream program is not the right next step if:

• You and your partner are trying to conceive right now; start with fertility-focused care
• You want an FDA-approved product; discuss an approved gel rather than treating a compounded cream as equivalent
• Your hematocrit—the share of your blood made up of red cells—is already high and has not been evaluated

Clinical guidance · FDA compounding information · Product-specific transfer warning

Who made this comparison, and how should you use it?

This is an editorial comparison of care choices, research and public provider disclosures. It can help you prepare questions, but it cannot interpret your lab results or choose a prescription for you.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

We're not a clinic, a pharmacy, or a lab. We don't prescribe anything. What we do is read the guidelines, read the trials, fetch the actual pricing pages, and write down what's there—including material limitations. Our method is documented in How We Review TRT Providers.

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.

→ Map your situation with Find My TRT Path—use your priorities to organize the care routes and questions to discuss with a clinician. The tool is educational and non-diagnostic; it does not interpret laboratory values, determine medical eligibility or guarantee a prescription. For replacement formats beyond cream, see enclomiphene vs TRT.

---

What's the real difference between enclomiphene and testosterone cream?

Enclomiphene is a pill that can raise testosterone by changing hormone signals in your brain, so your own testicles make more. Testosterone cream delivers testosterone through your skin from an outside source. That single difference drives the fertility question and helps explain why diagnosis comes before choosing a treatment. Comparative trial

Think of it like a thermostat and a space heater.

Your brain runs a thermostat. The hypothalamus signals the pituitary, which releases LH (luteinizing hormone)—the “make testosterone” signal—and FSH (follicle-stimulating hormone), which helps support sperm production. Your testicles respond to those signals when the system is able to work. Endocrine Society

Enclomiphene turns the thermostat up. It's a SERM — a selective estrogen receptor modulator, a drug that blocks estrogen's effects in some tissues. Estrogen is part of what tells your brain to ease off on LH. Block that message and your brain pushes harder. In the studied men, LH and FSH rose. Their own testicles got a louder signal. Clinical trial

Testosterone cream is the space heater. It warms the room directly. It doesn't care what the thermostat says. And because your brain now detects testosterone from outside the body, it turns the thermostat down—LH and FSH can drop. That suppression is a clinically important consequence, especially for sperm production. American Urological Association/American Society for Reproductive Medicine (AUA/ASRM) guidance

One more thing worth knowing, because it reframes this whole question:

“Testosterone therapy” and “testosterone replacement therapy” are not always used to mean the same thing. Guidelines discuss medicines that raise testosterone through different mechanisms, including SERMs. Enclomiphene does not contain testosterone: it is a non-testosterone alternative, not TRT, and calling it “natural TRT” blurs that distinction. AUA/ASRM guidance

---

What can LH tell you—and what can it not decide?

LH helps a clinician distinguish a testicular problem from a problem with the signals reaching the testes. Low or inappropriately normal LH alongside confirmed low testosterone can suggest secondary hypogonadism; high LH can suggest primary hypogonadism. Neither pattern, by itself, proves that enclomiphene will work or that testosterone cream is appropriate. Endocrine Society

This is the section we'd keep if we had to delete the rest of the page.

Doctors split low testosterone into two broad buckets:

Secondary (the signal is weak). Testosterone is low and LH is low or “inappropriately normal”—meaning the response is lower than expected for that testosterone level. Obesity, medicines or disease affecting the hypothalamus or pituitary can contribute. It does not mean the testicles are automatically fine or that a SERM will fix the cause. Endocrine Society's 2026 statement

Primary (the factory is struggling). Testosterone is low and LH is high: the brain is already sending a strong signal, but the testes are not making enough testosterone. That makes a treatment based on increasing the signal less likely to address the problem. Mixed causes are also possible. Diagnostic guidance

The enclomiphene-versus-gel trials discussed here studied men with secondary hypogonadism. The 2025 review excluded primary hypogonadism and pooled 10 trials of clomiphene or enclomiphene, not 10 enclomiphene-only trials. Systematic review

So here's the practical question: does the panel you're about to pay for actually measure LH?

What three online providers' starting lab panels include

Provider-stated contents on public pages checked September 21, 2026. A marker missing from a starter kit is not proof that the clinician never orders it.

Sources: Hone's itemized laboratory schedule, Male Excel's test page, and Taurus's offer page. FSH is also relevant to classifying the cause and fertility evaluation, but it is not listed in Hone's or Male Excel's starter panels checked here. Ask whether it is needed and separately ordered.

Let's be fair about what that table means.

Male Excel's published kit does include PSA—prostate-specific antigen—a blood marker used in prostate assessment. It does not list LH or a complete blood count. We did not establish whether its clinicians routinely add those tests, so the omission is a question to resolve—not evidence that missing tests are unnecessary. Male Excel test page

But if you landed here typing “enclomiphene vs testosterone cream,” you are specifically trying to understand the cause of low testosterone. A starter panel alone cannot close that loop.

So here's your move, and it costs nothing:

Before you pay anyone, ask: Does your evaluation include LH, any needed FSH testing, and appropriate baseline safety tests? If a test is separate, ask what it costs. Also ask how the clinician confirms a low testosterone result before recommending either treatment.

One more thing the Endocrine Society is blunt about: one low testosterone result is not enough to establish hypogonadism. Its current guidance calls for compatible symptoms or signs and consistently low testosterone, confirmed with repeat early-morning fasting measurements using an accurate test. Free testosterone is useful in selected situations; one cutoff is not a universal diagnosis. Guideline · July 2026 statement

If a program is ready to prescribe off one number, or off a questionnaire, that's a reason to slow down. A symptom checklist cannot replace the laboratory and clinical evaluation. Diagnosis guidance For the testing sequence, see TRT blood tests.

---

Affiliate disclosure: TRT Provider Guide may earn a commission through some provider links. Compensation does not determine our editorial conclusions. The research links and care-route guidance below do not guarantee treatment or a prescription. Affiliate disclosure · How We Review TRT Providers.

→ Review Hone Health's current lab panel and membership pricing

Hone's Premium panel includes LH, a full blood count and PSA, and its medication menu lists both compounded enclomiphene and compounded testosterone cream. The initial at-lab panel is listed at $65 as of September 2026; medications cost extra and a clinician must decide what is appropriate. This is a direct link to Hone's published plan information, not a clinical eligibility test.

---

Does enclomiphene raise testosterone as much as a testosterone cream?

The pooled comparison found no statistically significant difference in total testosterone between SERM treatment and testosterone gel. That is not proof of equal symptom relief—and it is not a trial of compounded testosterone cream. Systematic review

Claims that enclomiphene is “gentler” or testosterone is “stronger” need a defined outcome. The trials don't support either as a blanket description.

Here's what was actually tested.

The head-to-head trials

Sources: Kim trial record, Wiehle trial, and Hohl review, including its study-characteristics table.

The pooled numbers, SERM versus testosterone gel:

• Total testosterone: no significant difference. Mean difference 5.41 ng/dL (95% CI −43.44 to 54.27; p = 0.83). Certainty: moderate.
• LH: 7.13 IU/L higher on the SERM (5.12 to 9.13).
• FSH: 6.98 IU/L higher on the SERM (3.04 to 10.93). Certainty: low.
• Sperm concentration: 70.40 million/mL higher on the SERM (41.62 to 99.18).
• Risk of falling below 15 million/mL sperm concentration: RR 0.10 (0.04 to 0.23). Roughly a 90% lower risk of dropping under that threshold compared with the gel.
• Estradiol: 18.35 pg/mL higher on the SERM (6.66 to 30.04). Estradiol is a form of estrogen. That is a higher average hormone level in this comparison—not proof of more estrogen-related symptoms in every patient.

These are pooled differences versus gel, not a prediction about your response or a compounded cream. CI means confidence interval; RR means relative risk. The confidence intervals describe uncertainty in the estimated differences. Full analysis and evidence ratings

If you remember one sentence from this page, make it this one:

In the pooled gel comparisons, testosterone levels did not differ significantly, but sperm and hormone-signaling results did. No trial here establishes equivalent outcomes for a compounded cream.

What those trials do not establish

This is where we part company with most of the internet.

Every head-to-head testosterone comparison included here used a testosterone gel. Not one used a compounded testosterone cream.

So a claim that these studies directly prove enclomiphene beats testosterone cream for fertility goes beyond the data. Exogenous testosterone's suppression of sperm production is a legitimate concern for cream too, but the size of the gel-trial difference cannot simply be copied onto every cream. Trial evidence · Fertility guidance

A few other honest limits:

• The follow-up was short. Across the pooled trials, treatment ran anywhere from 2 to 30 weeks. This review does not establish years-long comparative outcomes.
• The men studied were specific. Study-average ages ranged from about 34 to 60.5 years and average BMIs from 30.5 to 46.4. BMI, or body mass index, is a height-and-weight measure. Those are study averages—not the age or weight limits for every participant or patient.
• Safety data is thin. The 2025 review says it remains underpowered for safety endpoints. Similar short-term adverse-event counts do not prove equal long-term safety.
• Age and weight need a careful reading. An exploratory study-level analysis found smaller SERM-versus-placebo testosterone effects in trials with older average ages (p = 0.0431) and higher average BMI (p = 0.0008). It does not predict how a particular 52-year-old will respond, and it was not proof that cream becomes the better treatment above a given age or weight.

Review methods, results and limitations

And one more, which is the most important honest limitation on this page.

The thing enclomiphene's biggest regulatory test never measured

Renable Pharma sought European authorization for enclomiphene as EnCyzix, for hypogonadotropic hypogonadism in overweight men. Its studies measured testosterone and sperm outcomes, but those results did not establish the symptom benefits the regulator required.

On 25 January 2018, the European Medicines Agency's Committee for Medicinal Products for Human Use issued a negative opinion. The European Commission refused authorization on April 6, 2018. EMA assessment · Commission refusal record

The committee's stated reasons are worth reading carefully. In summary, the evidence did not adequately demonstrate clinically meaningful symptom benefits despite higher testosterone, and venous thromboembolism—blood clots in the veins—was among its safety concerns. The magnitude of that risk remained uncertain. EMA benefit–risk assessment, sections 3 and 4

Read that again. The regulator didn't say the drug doesn't raise testosterone. It said raising testosterone isn't the same thing as demonstrating a clinical benefit—and this application had not closed that gap.

That's a European decision, not an FDA one, and it concerned a specific product from a specific company. It is not proof that no patient can feel better. It is a reason not to promise symptom relief or dismiss a clot-risk concern simply because hormone numbers improve. EMA assessment

Testosterone cream has a different limitation. It's actual testosterone replacement, which means fertility and monitoring matter—but evidence for an FDA-approved testosterone product does not automatically establish the safety or effectiveness of a particular compounded cream. FDA compounding information

So the choice isn't "weak drug versus strong drug." It's two different strategies, each with a different gap in its evidence.

---

Which one is better if fertility matters?

Exogenous testosterone—including cream—can suppress the hormone signals that drive sperm production. The Endocrine Society recommends against testosterone therapy when fertility is planned in the near term; AUA/ASRM guidance discusses SERMs as a conditional option for some infertile men with low testosterone, not as a guarantee of fertility. Endocrine Society · AUA/ASRM

This is the part of the decision people get wrong, and it's a part that can take time to address.

Here's the distinction in the guidance:

Sources: Endocrine Society recommendations and AUA/ASRM Part II, medical interventions for fertility.

Look at the first two rows together.

Advice against a fertility-suppressing treatment is not the same thing as strong evidence that a particular alternative will help you have a child. “Conditional” means the right choice depends on the individual circumstances; Grade C indicates low-quality evidence in this guideline. It does not mean a named enclomiphene product has been approved.

That doesn't mean enclomiphene is a bad idea. It means the confidence gap is real and you should know about it.

Language we're going to be careful with

Plenty of pages say enclomiphene "preserves fertility." We won't, and neither should anyone selling it to you.

What the enclomiphene trials actually showed is that sperm concentration was maintained in the men studied—men with secondary hypogonadism, over limited follow-up. That is a real, measured, meaningful finding. It is not a promise about you, your sperm, or your ability to have a child. Phase II trial · Pooled evidence

We also won't tell you testosterone will make you infertile, or that its fertility effects are always reversible. What we'll tell you is the mechanism: exogenous testosterone can suppress the signals that drive sperm production, which is why fertility should be addressed before treatment. AUA/ASRM

If you're trying to conceive right now, start with fertility-focused care

A general online TRT or enclomiphene program should not replace a reproductive evaluation.

See a urologist, a reproductive urologist, or an endocrinologist. Ask about semen analysis and a reproductive health evaluation before treatment is chosen. The goal is to find the cause, not simply raise testosterone. AUA/ASRM guidance

We'd genuinely rather lose you here than have you find this out in twelve months. For help organizing which care route to discuss and what to ask, use Find My TRT Path. It does not replace fertility testing or specialist care. Our TRT and fertility guide explains the next questions in more detail.

---

What exactly are you being offered?

Four different products get sold under similar-sounding names, and they are not interchangeable. Enclomiphene, clomiphene, compounded testosterone cream, and FDA-approved testosterone gel each carry different regulatory status, different evidence, and different legal handling. Before you pay, confirm in writing which one is actually being prescribed.

We built this checklist because “the oral option” and “the topical option” are not precise enough to identify a prescription.

Sources: Clomid labeling, FDA testosterone information, AndroGel labeling and FDA compounding information.

Here's a concrete example of why this checklist exists.

Male Excel's pages disagree about its oral option. Its pricing page and FAQ describe Triclozene as clomiphene citrate with thyroid medication and selenomethionine. Its TRT page also says it may prescribe enclomiphene citrate. We cannot tell from those pages which description will apply to your prescription. Get the exact ingredient list in writing; do not assume it is single-ingredient enclomiphene. Pricing page · FAQ · TRT page

We'll come back to that.

---

Is testosterone cream the same thing as testosterone gel?

No. FDA-approved testosterone gels exist, but the testosterone creams in the programs compared here are compounded and are not FDA-approved finished drugs. A cream does not inherit a gel's approval status, labeling, or evidence just because both go on skin. FDA testosterone information · Compounding information

AndroGel is a gel, not a cream. That matters here because approved gel—not compounded cream—was the comparator in the head-to-head studies. See testosterone cream vs gel for the product-format comparison.

An FDA-approved topical alternative: AndroGel 1.62% is an approved gel supplied in metered pumps and packets. Other products have their own formulations and instructions. Approval history does not establish that every older product is still marketed or in stock. AndroGel labeling

What to ask when a telehealth clinic sells you “testosterone cream”: Which pharmacy will prepare it, what ingredients will it contain, and which compounding framework applies? Section 503A and section 503B have different requirements; a pharmacy's licensing or registration is not approval of its compounded product. FDA compounding information

What compounding does and doesn't mean

Compounding can meet a patient's medical need when an approved product does not meet that need. It is subject to federal and state conditions; a custom strength or base is not, by itself, proof of superiority.

What it doesn't mean: that the product has been through FDA review for safety, effectiveness or manufacturing consistency. An FDA-registered outsourcing facility is not the same thing as an FDA-approved medicine. That's not a scandal. It's a structural fact about a different regulatory pathway, and it's one you should factor in. FDA compounding questions and answers

Ask why a compounded cream is being proposed instead of an FDA-approved testosterone product. A useful answer should explain a patient-specific need, not just convenience, “bioidentical” marketing, or a stronger-sounding concentration.

We'll deal with that head-on in a minute.

---

Is enclomiphene FDA-approved?

No. There is no FDA-approved standalone enclomiphene drug, and a compounded prescription is not an FDA approval. Enclomiphene is not federally scheduled like testosterone, but prescription and compounding requirements still apply. FDA bulk-substance policy · Current Category 1 list · DEA schedule

There's a confusing wrinkle here: being on an FDA list does not mean a medicine is FDA-approved.

The final 503A Bulks List identifies substances included through the rulemaking process. Category 1 of the interim list contains nominated substances still under evaluation; enclomiphene citrate appears on the version updated May 14, 2026. FDA list and policy

FDA describes an enforcement-discretion policy under specified conditions while evaluating eligible Category 1 substances. That is not blanket permission for any pharmacy to compound enclomiphene, and it is not a finding that the finished medicine is safe, effective or equivalent to an approved product. FDA interim policy

Different documents, different lists. Now you know why a listing can be real without being an approval.

The practical takeaway: the current compounding position is not the same as an approved drug's status. Ask the prescribing clinician and dispensing pharmacy which requirements apply to the exact preparation offered to you. That question matters for a long-term treatment plan.

One difference worth naming, because it's genuinely useful: testosterone is Schedule III; enclomiphene is not federally scheduled. The controlled-substance telemedicine requirements therefore affect testosterone differently, although both still require lawful prescribing and state-specific care. DEA schedule · Federal telemedicine rule

---

What does each one actually cost in year one?

Using Hone Premium's published prices, a 12-month budget example is $2,441 for enclomiphene and $2,670 for cream—a $229 difference. That assumes the listed medication prices, 12 monthly membership charges and the published testing steps; it is not a guaranteed first-year bill or proof that one treatment is always cheaper. Hone Premium

A $99 enclomiphene subscription at one company and a $250 cream program at another compare business models as well as medicines. The medication price alone does not tell you what evaluation and follow-up will cost.

So we did it the other way. We priced both medications inside one membership, where the membership and included follow-up services stay the same. Initial confirmatory testing is a separate difference in Hone's published pathway.

Same platform, same membership, only the medicine and listed confirmatory step change

Hone Health Premium. Sources: its Premium membership page, updated September 9, 2026, and payment breakdown, updated September 17, 2026. Premium is the named comparison plan—not a claim that it is Hone's cheapest suitable plan. Premium plan · Annual program billed monthly

$229 apart. About $19 a month. The arithmetic is $65 + $1,860 + $516 for enclomiphene, and $65 + $25 + $1,860 + $720 for cream.

Hone says Premium includes scheduled follow-up labs, follow-up visits and shipping; medication costs are separate and may change with the prescription. This model assumes unchanged prices and no extra services beyond those stated. Any additional initial testing or patient-specific care must be added—not treated as free because no price is published. Plan details · Lab schedule

The $25 confirmatory panel is Hone's published TRT-specific billing step, not proof that one testosterone test is medically sufficient before prescribing enclomiphene. The page does not establish how every patient's collection timing or diagnostic workup is handled. Ask how repeat early-morning testing is completed for your evaluation. Hone's lab policy · Diagnostic guidance

Budget versus cash charged: Hone bills membership and medication separately, and says medication processing can occur before the prior supply runs out. The dates and quantities on an actual refill schedule can therefore change cash charged during the first 365 days. Billing and refill timing

Cream pricing across providers

Male Excel. Sources: maleexcel.com/treatments/hrt-costs/, hrt.maleexcel.com/pricing/, and maleexcel.com/treatments/male-hormone-test/ — all fetched 21 September 2026.

Male Excel publishes cream pricing on two of its own properties, and the numbers differ. Here's both, side by side:

Sources checked September 21, 2026: main pricing and HRT-subdomain pricing. These are two public price descriptions, not two verified selectable checkout offers. We could not establish which terms apply to a new patient, and the different pages do not prove an identical prescription or current discounted offer.

The first scenario preserves a useful apples-to-apples arithmetic comparison: $99 + 6 × $264 + 12 × $99 = $2,871, versus $99 + 6 × ($150 + $59 + $20) + 12 × $30 = $1,833. That's a $1,038 difference between the published scenarios, before the main site's shipping.

But six 60-day supplies cover 360 days, not a full year. A seventh shipment may be charged before day 365 and includes medicine for later use. The cash-flow examples assume uninterrupted treatment, unchanged quantities, the first medication charge on day zero, and the stated billing intervals. They are not patient quotes; added testing, other fees, different refill timing or a different prescription would change them.

The published prices conflict. Get the applicable terms in writing.

Get three numbers in writing before you enter a card: the exact 60-day medication charge, the monthly membership amount, and the shipping charge.

Two more things about the cream price are worth flagging:

1. The advertised $132/month includes a thyroid medication. Male Excel's main plan bundles desiccated thyroid tablets—a separate prescription medicine. A cream-only price isn't published on that page. Ask for one. Ask what diagnosis supports adding thyroid treatment. FDA also identifies animal-derived thyroid medicines as unapproved products; the exact manufacturer and product matter here too. Male Excel pricing · FDA thyroid information

2. Your renewal price can change with your prescription. Male Excel says its cream costs more when the prescribed amount increases. Ask for the refill price for the actual prescription, not a self-selected dose or a promise based on the starter amount. Male Excel FAQ

Taurus Meds. Its first-party offer advertises $49 for the blood-test/consultation step and $149/month for treatment. Taurus publicly markets injectable testosterone and enclomiphene; the checked offer also lists testosterone gel. We found no verified testosterone cream offering, so we have not included Taurus in the cream comparison. Taurus offer

The advertised calculation is $49 + 12 × $149 = $1,837, but it is not a verified all-in first-year total. The offer says no membership fees, while the Terms of Use contain a $17.99 recurring membership fee per billing period unless otherwise stated at purchase. Ask whether that clause applies, what the billing period is, and which ongoing labs and shipping are included. Offer · Terms, healthcare member fees

The alternative that does not require choosing either compounded product

Neither compounded enclomiphene nor compounded testosterone cream is an FDA-approved finished drug. That does not mean they are the only choices to discuss.

If you have a local doctor, an FDA-approved testosterone gel filled at a pharmacy is another treatment format to ask about. Confirm the exact product, insurance coverage, prior authorization and total visit/lab costs with your prescriber, pharmacy and plan. Do not assume a subscription is required or that insurance will pay. Approved gel information

FDA-approved clomiphene citrate products are a different oral option, used off-label in men. Clomiphene contains both enclomiphene and zuclomiphene; the latter persists longer. That chemical difference does not, by itself, prove that every man will have fewer side effects on enclomiphene. Ask the clinician about the evidence and the pharmacy about the actual price and availability. Clomiphene labeling

→ See Male Excel's cream pricing and program requirements

A daily needle-free cream is its advertised treatment format, but resolve the cream-only price, exact refill charge, required tests and thyroid question before paying. This link opens our sourced cream-program guide, not a prescription or eligibility decision.

---

What side effects and monitoring should you discuss?

Testosterone treatment can raise hematocrit and blood pressure, and topical treatment adds skin-transfer concerns. Enclomiphene has a smaller long-term safety evidence base, and the European review raised clot-risk concerns; neither is simply the “safer” choice. Testosterone labeling · EMA assessment

Sources: 2025 pooled research, FDA's testosterone-labeling update, AndroGel labeling and EMA review. These are discussion points, not an exhaustive side-effect list or a prescription-specific safety clearance. Study-level enclomiphene side effects are listed separately.

What a good monitoring plan looks like

A clinician should explain what will be checked, when, and how symptoms—not just a number—will guide reassessment:

• Before treatment: confirm the diagnosis and cause, review fertility plans, and obtain appropriate baseline safety tests. Blood counts and blood pressure are especially relevant when testosterone is considered.
• Prostate assessment: discuss PSA testing and other evaluation based on age, risk, symptoms and the clinician's assessment. PSA is not a universal “all clear” test.
• After treatment begins: review symptoms, adverse effects and appropriately timed testosterone measurements. Testosterone therapy also needs follow-up blood-count monitoring; other tests depend on the person and medicine.
• If numbers improve but symptoms do not: reassess the diagnosis, treatment benefit and other possible causes rather than treating a higher dose as the automatic answer.

Endocrine Society monitoring recommendations · Current product safety information

That last one deserves a moment. Fixing a laboratory number does not prove that treatment is solving the problem that brought you in. Any decision to change or discontinue medication belongs with the prescriber, not a self-directed trial.

And do not confuse a provider's advertised peak testosterone result with a treatment goal. The measurement's timing, study design, symptoms and adverse effects matter; a larger number is not proof of a better outcome. Product-specific laboratory timing and monitoring

The labeling has changed. In 2025 FDA required blood-pressure warnings and changes to the earlier cardiovascular boxed-warning language. In June 2026 it also requested removal of the age-related-hypogonadism limitation and revisions to prostate/BPH warnings; that announcement does not mean every individual label has already been revised. Neither change approves compounded cream or establishes treatment eligibility from age or symptoms alone. FDA 2025 update · FDA's current testosterone page · Endocrine Society, July 2026

---

When does skin-transfer risk make cream a poor fit?

Topical testosterone can expose another person through contact with treated skin. Approved AndroGel products carry a boxed warning about secondary exposure in children; a compounded cream needs its own clear written precautions rather than instructions copied from a different formulation. AndroGel labeling

This is a household compatibility question, not a small-print detail.

For AndroGel 1.62% specifically, the label includes these precautions:

• Wash your hands with soap and water immediately after applying
• Cover the application site with clothing once it's dry
• Wash the site thoroughly before any expected skin-to-skin contact

Application sites and waiting periods are product-specific. Do not borrow a gel's application instructions for a compounded cream. Ask the prescriber and pharmacist how to prevent transfer with the exact product supplied. Product instructions

If accidental skin exposure occurs, the label advises prompt washing with soap and water. A child, pregnant person or anyone developing signs of exposure needs prompt medical advice.

Signs of accidental exposure in a child can include early pubic hair, enlargement of the genitals, erections or sexual behavior, and behavior changes including aggression. In a woman, changes in body hair and an unusual increase in acne. Report suspected exposure to a clinician. Secondary-exposure warning

Credit where it's due: Male Excel publishes a secondary-exposure warning and a Schedule III disclosure on its own site. That is useful disclosure, not proof that its cream has an FDA-approved label. Male Excel safety text

There is also a practical problem to resolve: its cream page and general safety text do not describe application sites consistently. Get written directions for the exact dispensed cream instead of choosing between conflicting web instructions. Cream page · General safety instructions

This isn't meant to scare you. If daily contact with a child or partner makes transfer precautions impractical, say so before treatment is selected. An oral medicine removes this particular skin-transfer pathway; it does not remove the need for an appropriate diagnosis or a risk discussion.

---

Can you take enclomiphene and testosterone cream together?

Do not treat enclomiphene plus testosterone cream as a proven fertility-preservation strategy. The head-to-head trials discussed above compared alternatives; they did not establish the safety or fertility benefits of combining them. Comparative trials · AUA/ASRM fertility guidance

The combination raises a fair question because the two medicines affect the hormone feedback system differently. That mechanism is not, by itself, evidence that combining them protects sperm production.

If a provider offers a combination, ask what has actually been studied with the proposed formulation. Uncontrolled observations, especially from a company selling the treatment, cannot establish that a combination caused an improvement or that fertility was preserved.

If a combination protocol is offered to you, here's the question to ask:

“Can you show me LH, FSH and semen results from research on this combination—not just testosterone numbers?”

Because the testosterone number isn't what a fertility claim is supposed to protect. Even LH and FSH alone are not proof of preserved sperm production, pregnancy or live birth. A fertility-focused clinician can help assess what evidence is relevant. AUA/ASRM

We're not going to tell you how to combine them. That's a clinician's call with real trade-offs, and any page handing you a protocol is handing you something it shouldn't.

---

Can you switch from one to the other later?

A clinician can assess switching in either direction, but there is no universal transition schedule. Prior testosterone use can affect hormone signals and fertility testing, so the reason for switching, current treatment and follow-up plan matter. AUA/ASRM

Testosterone supplies hormone from outside the body and can suppress LH and FSH. Recovery after it is withdrawn varies, and a page cannot predict a personal timeline or say that someone must wait for complete recovery before any alternative can be considered.

If enclomiphene doesn't produce the response you and your clinician were hoping for, the next step is reassessment—not an automatic move to cream. Replacement may be discussed when appropriate, but symptoms, diagnosis, fertility and safety still matter.

One interesting detail from the pharmacology work: researchers found testosterone and LH effects persisted for at least seven days after enclomiphene was stopped. That study finding is not a washout period or switching instruction. Pharmacology study

What we're not going to give you is a taper, a restart protocol, doses, or timing. That's genuinely clinician territory, and getting it wrong has consequences. If you're currently on one and considering the other, that conversation belongs with the person who can order labs and watch what happens.

---

Which providers actually prescribe each one?

Hone's Premium documents clearly list both compounded enclomiphene and compounded testosterone cream. Male Excel clearly markets cream but has conflicting oral-drug descriptions; Taurus advertises enclomiphene and gel, not a verified cream offer. This is a comparison of published options—not a clinical ranking or a guarantee of availability. Hone · Male Excel · Taurus

Provider-stated facts checked September 21, 2026.

Sources: Hone plan, Hone labs, Male Excel pricing, Male Excel TRT page, Male Excel kit, Taurus offer and Taurus terms.

The thing we have to tell you about Male Excel

Male Excel is a commercial partner for TRT Provider Guide, and the product distinction still comes first.

Male Excel's public pages do not give one consistent answer about the oral medicine. The pricing page identifies Triclozene as clomiphene citrate with thyroid medication and selenomethionine; another treatment page mentions enclomiphene. Those are not interchangeable descriptions. If you specifically want single-ingredient enclomiphene, do not treat a branded blend as the same prescription. Pricing · TRT page

But if the cream is what you're after, here's why the oral-menu uncertainty may not decide your choice.

Male Excel advertises a daily compounded cream, clinician access and a cash-pay care model. Its public pages disclose transfer risk and the possibility of an in-person examination. Those are useful details for someone already discussing topical replacement—but they do not show that a compounded cream is better than an approved gel, or that flexible prescribing is unique to cream. Male Excel pricing and service details · Safety and access information · Approved gel options

Our editorial view: It belongs in a cream-program comparison after diagnosis, fertility and topical-treatment fit are resolved. Before paying, resolve the price conflict, baseline/repeat testing and the separate thyroid medication. An aversion to needles does not, by itself, favor compounded cream over an approved gel.

And if you're the reader that limitation disqualifies—you want clearly identified enclomiphene, or you want an FDA-approved product—don't just close the tab. Take the product and testing questions to a clinician who can evaluate both, or use Find My TRT Path to organize the care routes worth discussing.

Which one is right for which reader

→ Review Hone Health's current lab panel and membership pricing Useful when you want a provider's published evaluation process and both medication options in one clearly identified plan. This is a research link; treatment still depends on clinical assessment.

→ See Male Excel's cream pricing and program requirements Useful when topical TRT is already the discussion and you need the cream-specific cost, testing and thyroid questions answered before paying.

→ Check Taurus Meds' enclomiphene offer and unresolved terms Useful for investigating its advertised enclomiphene program—not a recommendation to pay before the membership-fee, testing and cancellation questions are resolved.

What should you confirm about state access, pharmacy and cancellation?

These details can change whether an advertised medicine is a usable option. Public disclosures do not establish that a particular clinician is available, licensed for your location or able to prescribe your requested treatment.

Sources: Hone state list, Hone lab schedule, Hone pharmacy disclosure, Hone cancellation policy, Hone consult-history export, Male Excel FAQ, Taurus terms and Taurus refund policy. Pharmacy names above are provider-stated disclosures, not an independent license inspection or verification of the pharmacy assigned to you.

For Taurus, clarify what you pay before the clinician decides. Its offer describes a medication-payment step before the consultation, so do not assume the advertised $49 is the most you can be charged before that decision. Its “no membership fee” offer also needs to be reconciled with the $17.99 clause in its terms. Offer sequence · Fee terms

For any program, ask who will handle a delayed refill, what monitoring must be current before another prescription, and what happens if your state or in-person requirements change. A refill reminder is not a guarantee that medication will ship.

---

When is specialist evaluation the better starting point?

Some situations need a more complete evaluation than a routine online treatment program can provide. Cancer history, high blood counts, severe untreated sleep apnea, recent cardiovascular events, suspected pituitary or testicular disease and fertility concerns can change the assessment or make testosterone inappropriate. Endocrine Society

Arrange appropriate clinical evaluation before choosing a subscription when:

• You're trying to conceive now, or soon. Start with fertility-focused care.
• You have a history of prostate cancer or breast cancer. Specialist review matters; a general questionnaire cannot clear this history.
• Your hematocrit or hemoglobin is already high. The cause and treatment implications need review.
• You have untreated, severe sleep apnea or uncontrolled blood pressure. Tell the clinician before discussing testosterone.
• You've had a recent heart attack or stroke. The Endocrine Society recommends against testosterone therapy within the preceding six months.
• Your results suggest a pituitary or testicular problem. Very low testosterone, abnormal prolactin or an unexpected LH/FSH pattern needs clinical interpretation; imaging is not decided by a single number on this page.
• You have vision changes, loss of smell, or headaches alongside low testosterone. Get evaluated.

Clinical guidance · Current testosterone safety information

Only one test—or an afternoon test—is a reason to complete the diagnostic workup, not necessarily a reason for a specialist. Primary care can often arrange the first evaluation. Whether it requires an in-person examination depends on the findings. Endocrine Society, July 2026 Our online vs local TRT guide explains the care-model tradeoffs.

Get emergency care for chest pain, sudden trouble breathing, or a sudden severe headache with vision changes. New one-sided leg swelling or calf pain needs prompt medical assessment, especially with chest pain or breathlessness. Do not wait for an online refill appointment. Blood-clot warnings

---

Can these medicines be prescribed online under current rules?

Testosterone in any form—cream included—is a Schedule III controlled substance; enclomiphene is not federally scheduled. The current federal temporary telemedicine rule extends controlled-substance prescribing flexibilities through December 31, 2026, subject to its conditions and other federal and state requirements. DEA schedule · DEA/HHS rule

This is a real difference between the two options, and it's the kind of thing you should ask about before a refill problem develops.

The Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications took effect January 1, 2026. It permits qualifying audio-video prescribing without a prior in-person evaluation during the extension; it does not guarantee access, override state rules or waive the need for a legitimate clinical prescription. Federal rule, background and operative provisions

A proposed special-registration framework is not the same thing as a final rule already governing your care. We are not relying on a forecast of when a replacement will be issued. Male Excel's own disclosure says DEA and state law may require an in-person examination. DEA/HHS rule · Male Excel disclosure

We're not going to turn that date into a countdown, and you should be suspicious of anyone who does. It's not a reason to rush. It's a question to ask:

"If the telemedicine rules change, what happens to my refills — and would I need an in-person visit?"

Enclomiphene is outside these testosterone controlled-substance requirements, not outside medical practice law. State licensing, lawful compounding and the clinician's judgment still matter. FDA compounding policy

---

What we actually verified

We checked public research, regulatory records and provider disclosures on September 21, 2026. This was a source audit—not medication use, a test purchase, a support-response test, a completed checkout or an independent inspection of clinicians and pharmacies.

Medical and regulatory sources checked:

The Endocrine Society's testosterone guideline and July 2026 statement; AUA/ASRM's published 2021 Part II male-infertility guidance; the Wiehle and Kim comparative trial records and Hohl's 2025 pooled research; EMA's EnCyzix assessment and the European Commission refusal; FDA testosterone updates, compounding policy and its May 2026 Category 1 list; current AndroGel and clomiphene labeling; FDA thyroid information; and the DEA/HHS fourth temporary extension.

Provider pages checked:

Hone's Premium medication prices, lab schedule, payment breakdown, state list and cancellation disclosures; Male Excel's main and subdomain pricing, hormone-test page, FAQ and treatment descriptions; and Taurus's first-party offer, terms and refund policy. The tables reproduce what those pages state and identify conflicts rather than choosing the more favorable description.

Confirmed from the sources:

The gel-versus-cream evidence boundary; the six pooled effect estimates; the distinction between a hormone result and a symptom or fertility outcome; the current compounded-versus-approved product distinction; the public prices used in the arithmetic; and the December 31, 2026 federal extension date.

Not independently established:

A patient-specific prescription, complete checkout total, assigned clinician or pharmacy, professional-license status for that assignment, actual turnaround, individual treatment response, fertility outcome, refund experience or support quality. Male Excel's applicable price/oral-drug description and Taurus's fee terms remain unresolved in their public materials. These are not silently treated as confirmed benefits.

Claims we did not turn into evidence:

Male Excel's “20x more powerful” language does not establish clinical superiority, and “bioidentical” does not establish FDA approval. We did not reinterpret an undefined marketing comparison as a verified concentration or outcome claim. Male Excel pricing · FDA compounding information

Our editorial judgments:

Who each option fits, and which published care details deserve attention. Those are conclusions we drew from the verified facts above—not individual medical recommendations or guarantees that a provider will prescribe.

Why there are no patient success stories on this page:

A quote about how someone felt is not evidence that either medication will work for you. We'd rather show you the trial numbers and let you judge.

Our full method: How We Review TRT Providers. Editorial standards · Corrections · Privacy.

---

Frequently asked questions

Neither medicine is universally better, and several common questions confuse evidence about testosterone gel with evidence about compounded cream. These answers keep the product, diagnosis and fertility limits separate.

Is enclomiphene better than testosterone cream?

Neither is universally better. The trials reviewed compared enclomiphene with testosterone gel, not cream; they found different hormone-signaling and sperm results, without establishing equal symptom benefit. The right discussion depends on the diagnosed cause, fertility plans, health history and exact product. Comparative trial · Pooled evidence

Does enclomiphene raise testosterone as much as a cream?

The cream-specific question has not been answered by the trials compared here. In pooled randomized data comparing SERM therapy with testosterone gel, the difference in total testosterone was 5.41 ng/dL — not statistically significant. That is no statistically significant difference—not proof of equivalence or a prediction about your prescription. Systematic review

Will testosterone cream make me infertile?

Exogenous testosterone can suppress the hormone signals that drive sperm production, but that is not a prediction of infertility in every person. Fertility and recovery cannot be guaranteed. If fertility matters, see a fertility-aware clinician before treatment is chosen. Endocrine Society · AUA/ASRM

Does enclomiphene work if my LH is already high?

High LH with confirmed low testosterone can suggest primary hypogonadism, where the testes are not responding adequately to an already strong signal. That can limit the usefulness of a stimulation approach, but one LH value is not enough to decide the cause or your treatment. The comparative research discussed here concerns secondary hypogonadism. Diagnostic guidance · Trial

Is testosterone cream FDA-approved?

The testosterone creams compared on this page are compounded and are not FDA-approved finished products. FDA-approved testosterone gels exist, but a compounded cream—or a compounded gel—does not inherit their approval. FDA testosterone information · Compounding information

Is enclomiphene FDA-approved?

No standalone enclomiphene drug is FDA-approved. Its presence on an interim FDA bulk-substance list is not approval or blanket permission to compound it; FDA's enforcement-discretion policy has conditions. European regulators also refused EnCyzix authorization in 2018, a separate decision about a specific application. FDA policy · EMA assessment

How much does enclomiphene cost per month?

Hone Premium lists it from $43/month, separate from a $155/month membership and initial testing. Taurus advertises $149/month after a $49 introductory step, but its recurring-fee terms conflict with the no-membership-fee offer. These are provider-stated figures, not interchangeable all-in quotes. Hone · Taurus offer · Taurus terms

How much does testosterone cream cost per month?

Hone Premium lists compounded cream at $60/month, plus its $155/month membership. Male Excel's main page lists cream with thyroid from $132/month equivalent, plus $99/month membership and an initial $99 charge; medication is billed in 60-day supplies and shipping is extra. Its subdomain publishes different terms, so obtain the actual refill schedule and written quote. Hone · Male Excel main pricing · Subdomain pricing

Can I take enclomiphene and testosterone cream at the same time?

A clinician would need to assess that question. Do not assume a combination preserves fertility because testosterone, LH or FSH rises; the comparative trials here do not establish combination outcomes. Ask about semen and clinical outcomes, not just hormone numbers, and do not combine or change medicines on your own. Trial · Fertility guidance

What's the difference between clomiphene and enclomiphene?

Clomiphene contains two geometric isomers—enclomiphene and zuclomiphene—not two mirror-image molecules. Zuclomiphene persists longer, but that does not prove a universal side-effect advantage for enclomiphene. FDA-approved clomiphene products are approved for ovulatory dysfunction in women and used off-label in men; standalone enclomiphene is not approved. Clomiphene label · FDA policy

Does insurance cover either one?

Do not assume coverage for a compounded medicine or a telehealth membership. Ask the plan about the exact medication, dispensing pharmacy, clinician visits and laboratory charges separately. An FDA-approved testosterone gel is a different product to discuss with your prescriber and insurer; approval does not guarantee coverage. Approved gel information

Can I get either one without a blood test?

A questionnaire alone cannot establish testosterone deficiency or determine the cause. Current Endocrine Society guidance requires matching symptoms or signs plus consistently low testosterone, confirmed with repeat early-morning testing. Completing a lab purchase or online form does not guarantee a prescription. Guideline · July 2026 statement

---

The bottom line

The question isn't which one raises a number faster. It's whether stimulating your own production or supplying testosterone fits the diagnosed problem. The trials discussed here answer parts of that question for gel, not for a compounded cream.

The question is whether your body needs a louder signal or a direct supply — and whether you might want children in the next few years. Household transfer risk and product approval also change the options worth discussing. LH helps; it does not make the decision by itself. Clinical guidance · Comparative evidence

Cost also needs context. The same-platform example differs by about $19 a month, but other plans, prescription quantities, extra tests and billing schedules can change the comparison. A low medication price is not a complete care quote.

So the most useful thing you can do this week isn't to pick a subscription. It's to arrange a clinician-led evaluation and bring these questions:

This is a discussion checklist, not a treatment-selection test. You do not need to enter personal lab values into a website to use it.

Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

---

TRT Provider Guide is the independent decision resource for testosterone replacement therapy care. We are not a clinic, pharmacy, laboratory, drug manufacturer, insurer, or medical practice. This page is editorial research based on clinical guidance, regulatory records, published comparative trials and dated provider disclosures. It is not medical advice and is not a substitute for evaluation by a licensed clinician.

Last verified: September 2026.

Sources

1. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy
2. https://www.endocrine.org/news-and-advocacy/news-room/2026/statement-on-testosterone-replacement-therapy
3. https://www.asrm.org/practice-guidance/practice-committee-documents/diagnosis-and-treatment-of-infertility-in-men-aua-asrm-guideline-part2/
4. https://pubmed.ncbi.nlm.nih.gov/25044085/
5. https://pubmed.ncbi.nlm.nih.gov/26496621/
6. https://pubmed.ncbi.nlm.nih.gov/23875626/
7. https://www.scielo.br/j/aem/a/jyRkLt4MbHqk3tpgvsMfMmP/?lang=en
8. https://www.ema.europa.eu/en/documents/assessment-report/encyzix-epar-public-assessment-report_en.pdf
9. https://ec.europa.eu/health/documents/community-register/2018/20180406140278/anx_140278_en.pdf
10. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/testosterone-information
11. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-issues-class-wide-labeling-changes-testosterone-products
12. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f4e8d29b-8707-4d47-e053-2a95a90aecee
13. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
14. https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503a-fdc-act
15. https://www.fda.gov/media/94155/download?attachment=
16. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=2ca373c1-4dba-4126-8616-5c533d606fe5
17. https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled
18. https://help.honehealth.com/hc/en-us/articles/40162141159319-Hone-Premium-Membership-Full-Clinical-Insight-for-Men
19. https://help.honehealth.com/hc/en-us/articles/40162286881431-Men-s-Lab-Schedule-on-the-Premium-Plan
20. https://help.honehealth.com/hc/en-us/articles/40165199078423-Hone-Men-s-Premium-Membership-Overview-and-Payment-Breakdown
21. https://help.honehealth.com/hc/en-us/articles/40162125713815-Hone-Health-Order-Cancellation-and-Refund-Policy
22. https://help.honehealth.com/hc/en-us/articles/40162108823319-Hone-Health-Service-Availability-by-State-2026
23. https://help.honehealth.com/hc/en-us/articles/40162334879383-Where-does-Hone-get-their-pharmaceuticals-and-supplements
24. https://help.honehealth.com/hc/en-us/articles/40165235275927-How-to-Export-Your-Consult-History-from-Hone-Health
25. https://maleexcel.com/treatments/hrt-costs/
26. https://hrt.maleexcel.com/pricing/
27. https://maleexcel.com/treatments/male-hormone-test/
28. https://maleexcel.com/faq/
29. https://maleexcel.com/treatments/trt-online/
30. https://maleexcel.com/treatments/testosterone-cream/
31. https://www.fda.gov/drugs/enforcement-activities-fda/fdas-actions-address-unapproved-thyroid-medications
32. https://taurusmeds.com/pages/testosterone-49
33. https://taurusmeds.com/legal/terms
34. https://taurusmeds.com/legal/refunds
35. https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf